home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Merit Medical Systems, Inc. - Common Stock (NQ:MMSI)

88.22 +0.83 (+0.96%)

Streaming Delayed Price Updated: 10:54 AM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merit Medical Systems, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

3 Reasons to Avoid MMSI and 1 Stock to Buy Instead

April 03, 2025

Since April 2020, the S&P 500 has delivered a total return of 121%. But one standout stock has doubled the market - over the past five years, Merit Medical Systems has surged 247% to $105.49 per share....

Via StockStory

Topics Stocks Supply Chain

How Do Investors Really Feel About Merit Medical Systems? ↗

April 02, 2025

Via Benzinga

This Merit Medical Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗

March 28, 2025

Via Benzinga

Assessing Merit Medical Systems: Insights From 12 Financial Analysts ↗

March 28, 2025

Via Benzinga

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

March 25, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers.

Via StockStory

Merit Medical Systems Stock: A Deep Dive Into Analyst Perspectives (13 Ratings) ↗

February 26, 2025

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

3 Small-Cap Stocks Skating on Thin Ice

March 12, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For

February 26, 2025

Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know.

Via StockStory

Merit Medical Systems’s (NASDAQ:MMSI) Q4 Sales Top Estimates

February 25, 2025

Medical device company Merit Medical Systems (NASDAQ:MMSI) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.4% year on year to $355.2 million. The company expects the full year’s...

Via StockStory

Merit Medical Systems (MMSI) Q4 Earnings Report Preview: What To Look For

February 24, 2025

Medical device company Merit Medical Systems (NASDAQ:MMSI) will be announcing earnings results tomorrow after market close. Here’s what to look for.

Via StockStory

Looking Into Merit Medical Systems's Recent Short Interest ↗

February 12, 2025

Via Benzinga

9 Analysts Have This To Say About Merit Medical Systems ↗

January 21, 2025

Via Benzinga

What 8 Analyst Ratings Have To Say About Merit Medical Systems ↗

December 31, 2024

Via Benzinga

Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack

February 14, 2025

Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers.

Via StockStory

Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

February 14, 2025

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including...

Via StockStory

Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3

February 13, 2025

Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers.

Via StockStory

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest

February 13, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Merit Medical Systems...

Via StockStory

Price Over Earnings Overview: Merit Medical Systems ↗

December 19, 2024

Via Benzinga

Merit Medical Systems Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) ↗

December 11, 2024

Via Benzinga

How Is The Market Feeling About Merit Medical Systems? ↗

November 18, 2024

Via Benzinga

Where Merit Medical Systems Stands With Analysts ↗

October 18, 2024

Via Benzinga

Merit Medical Systems To Purchase Cook Medical's Lead Management Portfolio In $200M Deal, Seeks To Enhance Its Position In Cardiac Intervention Market ↗

September 17, 2024

Merit Medical Systems plans to acquire Cook Medical's lead management portfolio for $210 million, aiming to boost its electrophysiology and cardiac rhythm management business. The deal is expected to...

Via Benzinga

Key Takeaways From Merit Medical Systems Analyst Ratings ↗

September 16, 2024

Via Benzinga

9 Analysts Assess Merit Medical Systems: What You Need To Know ↗

August 28, 2024

Via Benzinga

So Much For Expecting The Fed To Stick The Landing ↗

August 04, 2024

Now is not the time to be fully invested.

Via Talk Markets

Topics Economy

Assessing Merit Medical Systems: Insights From 6 Financial Analysts ↗

August 02, 2024

Via Benzinga

What 9 Analyst Ratings Have To Say About Merit Medical Systems ↗

July 16, 2024

Via Benzinga

Analyst Expectations For Merit Medical Systems's Future ↗

June 28, 2024

Via Benzinga

MMSI Stock Earnings: Merit Medical Systems Beats EPS, Beats Revenue for Q2 2024 ↗

August 01, 2024

MMSI stock results show that Merit Medical Systems beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com